All News

Navigating a Colorectal Cancer Diagnosis at a Young Age

March 26th 2025, 1:00pm

Article

Melissa Ursini discussed her experience with a colorectal cancer diagnosis at age 37, highlighting her insights during Colorectal Cancer Awareness Month.

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

March 25th 2025, 9:00pm

Article

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.

Top 3 Takeaways From ASCO GU 2025

March 25th 2025, 8:16pm

Video

Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.

New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application

March 25th 2025, 7:05pm

Article

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach this stage.

Navigating a Diagnosis of Diabetes and Chronic Lymphocytic Leukemia

March 25th 2025, 5:00pm

Article

Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.

Olvi-Vec Shows Responses and Tolerable Safety in Small Cell Lung Cancer

March 25th 2025, 4:14pm

Article

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer

March 25th 2025, 3:34pm

Article

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced non-small cell lung cancer.

Raising Awareness for Colorectal Cancer, On the Rise in Younger Adults

March 25th 2025, 1:00pm

Article

During Colorectal Cancer Awareness Month, Dr. Shyam Thakkar discussed rates of this disease in young adults, the role of AI and disparities in care.

Global Submission Seeks Approval for Sugemalimab Treatment in NSCLC

March 24th 2025, 9:00pm

Article

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 NSCLC following chemoradiotherapy.

Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer

March 24th 2025, 8:00pm

Video

Dr. Sheri Prentiss discusses what steps patients can take to ensure they're being screened for lymphedema prior to starting their breast cancer treatment.